Medi Radio Malaysia Sdn Bhd (“MRM”) has been established with the mission to improve patient’s quality of life and clinical outcome through cutting edge pharmaceutical interventions.

 

We are committed to establishing ourselves as the premier centralized pharmacy within the region offering a platform for pharmaceutical, research, and clinical trials advancements.

 

Essential building blocks of our product portfolio are conventional nuclear medicine products as Tc99m and I131 and novel Theranostics as Lu177, Ac225, Tb161 and Ga68 which we provide throughout Asia, together with training and support to our end users.